Table 1.
Clinical studies that reported insulin resistance markers in patients with Diabetes and coronavirus disease 2019
|
Ref.
|
Study design
|
Sample size
|
T2DM
|
Markers of IR
|
Age
|
Outcomes
|
Country
|
| Wang et al[57], 2021 | Retrospective | 172 | 72 | Hypertriglyceridemia (Fibrinogen, triglycerides, Serum ferritin | 66 (Median) | China | |
| Ren et al[53], 2020 | Retrospective | 151 | 39 | Triglyceride-glucose index | 59.5 (Mean) | Severity and mortality | China |
| Alcántara-Alonso[58], 2021 | Observational cohort | 43 | 25 | Triglyceride to high density lipoprotein cholesterol | 57.19 (Mean) | Incidence of acute kidney injury, requirement of invasive mechanical ventilation, vasopressor support, days of hospitalization and mortality | Mexico |
IR: Insulin receptor; T2DM: Type 2 diabetes mellitus.